CA
DGX icon

Commerzbank Aktiengesellschaft’s Quest Diagnostics DGX Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Hold
6,686
– – 0.03% 183
2026
Q1 		$1.31M Buy
6,686
+3,665
+121% +$712K 0.03% 186
2025
Q4 		$524K Buy
+3,021
New +$550K 0.01% 276
2020
Q2 		– Sell
-3,585
Closed -$288K – 189
2020
Q1 		$288K Buy
3,585
+512
+17% +$53K 0.01% 358
2019
Q4 		$328K Sell
3,073
-588
-16% -$61.3K ﹤0.01% 599
2019
Q3 		$392K Buy
3,661
+103
+3% +$10.6K ﹤0.01% 682
2019
Q2 		$362K Buy
3,558
+1,272
+56% +$122K ﹤0.01% 810
2019
Q1 		$206K Sell
2,286
-710
-24% -$61.5K ﹤0.01% 791
2018
Q4 		$249K Sell
2,996
-881
-23% -$82.6K ﹤0.01% 802
2018
Q3 		$418K Sell
3,877
-432
-10% -$47.4K ﹤0.01% 721
2018
Q2 		$474K Buy
4,309
+1,405
+48% +$146K ﹤0.01% 677
2018
Q1 		$291K Buy
2,904
+808
+39% +$82.8K ﹤0.01% 799
2017
Q4 		$206K Buy
+2,096
New +$199K ﹤0.01% 829
2017
Q2 		– Sell
-3,022
Closed -$297K – 752
2017
Q1 		$297K Buy
3,022
+442
+17% +$42.1K ﹤0.01% 795
2016
Q4 		$237K Buy
+2,580
New +$222K ﹤0.01% 855
2016
Q3 		– Sell
-4,307
Closed -$351 – 937
2016
Q2 		$351 Sell
4,307
-608
-12% -$46.3K ﹤0.01% 780
2016
Q1 		$351K Sell
4,915
-5,072
-51% -$340K ﹤0.01% 815
2015
Q4 		$710K Buy
9,987
+3,820
+62% +$257K 0.01% 763
2015
Q3 		$379K Sell
6,167
-10,958
-64% -$766K ﹤0.01% 883
2015
Q2 		$1.24M Sell
17,125
-1,496
-8% -$110K 0.01% 754
2015
Q1 		$1.43M Sell
18,621
-3,902
-17% -$279K 0.01% 700
2014
Q4 		$1.51M Sell
22,523
-22,988
-51% -$1.45M 0.01% 739
2014
Q3 		$2.76M Buy
45,511
+10,094
+29% +$622K 0.01% 659
2014
Q2 		$2.08M Sell
35,417
-3,203
-8% -$188K 0.01% 707
2014
Q1 		$2.24M Buy
38,620
+1,054
+3% +$56.5K 0.01% 682
2013
Q4 		$1.97M Sell
37,566
-13,257
-26% -$786K 0.01% 746
2013
Q3 		$3.14M Sell
50,823
-10,612
-17% -$635K 0.02% 613
2013
Q2 		$3.73M Buy
+61,435
New +$3.66M 0.02% 625

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Commerzbank Aktiengesellschaft's DGX Position: Q2 2026 in Review

Commerzbank Aktiengesellschaft held its Quest Diagnostics (DGX) position steady in Q2 2026 at 6,686 shares worth $1.42M. The position accounts for 0.03% of the portfolio, ranked #183.

Commerzbank Aktiengesellschaft first reported a position in DGX in Q2 2013 and has held it in 28 quarters since. The position peaked at $3.73M in Q2 2013. 736 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Commerzbank Aktiengesellschaft held 6,686 shares of Quest Diagnostics worth $1.42M as of Q2 2026.
  • Commerzbank Aktiengesellschaft left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.03% of Commerzbank Aktiengesellschaft's portfolio in Q2 2026, its #183 holding.
  • Commerzbank Aktiengesellschaft first reported a position in Quest Diagnostics in Q2 2013 and has held it in 28 quarters since.
  • Commerzbank Aktiengesellschaft's Quest Diagnostics position peaked at $3.73M in Q2 2013.
  • 736 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2026, filed 7 Aug 2026.